$0.22 0.00 (+2.27%)
11/30/2009 10:07 AM

Advanced Life Sciences Holdings, Inc. (ADLS)

CAPS Rating: No stars

A biopharmaceutical company focused on the discovery, development and commercialization of novel drugs in the areas of infectious disease, oncology and inflammation.

Results 1 - 2 of 2

Recs

2
Member Avatar JohnnyLC (99.90) Submitted: 5/29/2008 8:32:04 PM : Outperform Start Price: $2.20 ADLS Score: -66.03

Phase III results for Cethromycin looks good. Company planning on NDA submits in 3Q of this year but need a partnership to cover the 10M cost owned to Abbott upon filing of NDA. Company is undervalued right now but it all comes down to how good of a partnership deal they can negotiate. PPS has dropped low enough for me to make a gamble.

Recs

0
Member Avatar zzlangerhans (99.58) Submitted: 7/3/2007 3:22:43 PM : Outperform Start Price: $2.10 ADLS Score: -64.96

Likely FDA approval of cethromycin antibiotic which will have small market share, but company currently has tiny market cap.

Results 1 - 2 of 2

Featured Broker Partners